A Type 2 Diabetes-Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the Adcy5 Locus.

Tamara S Roman
Maren E Cannon
Swarooparani Vadlamudi
Martin L Buchkovich
Brooke N Wolford
Ryan P Welch
Mario A Morken
Romy Kursawe, The Jackson Laboratory
Arushi Varshney
Romy Kursawe
Ying Wu
Anne U Jackson
Michael R Erdos
Johanna Kuusisto
Markku Laakso
Laura J Scott
Michael Boehnke
Francis S Collins
Stephen C J Parker
Michael L. Stitzel, The Jackson Laboratory
Karen L Mohlke


Molecular mechanisms remain unknown for most type 2 diabetes genome-wide association study (GWAS) identified loci. Variants associated with type 2 diabetes and fasting glucose levels reside in introns of ADCY5, a gene that encodes adenylate cyclase 5. Adenylate cyclase 5 catalyzes the production of cyclic AMP, which is a second messenger molecule involved in cell signaling and pancreatic beta cell insulin secretion. We demonstrated that type 2 diabetes risk alleles are associated with decreased ADCY5 expression in human islets and examined candidate variants for regulatory function. rs11708067 overlaps a predicted enhancer region in pancreatic islets. The type 2 diabetes risk rs11708067-A allele showed fewer H3K27ac ChIP-seq reads in human islets, lower transcriptional activity in reporter assays in rodent beta cells (rat 832/13 and mouse MIN6) and increased nuclear protein binding compared to the rs11708067-G allele. Homozygous deletion of the orthologous enhancer region in 832/13 cells resulted in a 64% reduction in expression level of Adcy5, but not adjacent gene Sec22a, and a 39% reduction in insulin secretion. Together, these data suggest that rs11708067-A risk allele contributes to type 2 diabetes by disrupting an islet enhancer, which results in reduced ADCY5 expression and impaired insulin secretion.